UK Markets closed
NIKKEI 225
38,054.13 -502.74 (-1.30%) HANG SENG
18,230.19 -246.82 (-1.34%) CRUDE OIL
77.99 -1.24 (-1.57%) GOLD FUTURES
2,363.20 -0.90 (-0.04%) DOW
38,145.63 -295.91 (-0.77%) BTC-GBP
54,440.96 +1,606.93 (+3.04%)
Harvard Bioscience, Inc. (HBIO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:54PM EDT. Market open.
| Previous close | 3.1000 |
| Open | 3.1000 |
| Bid | 3.1000 x 100 |
| Ask | 3.1700 x 200 |
| Day's range | 3.1000 - 3.2199 |
| 52-week range | 3.0900 - 6.2000 |
| Volume | |
| Avg. volume | 100,733 |
| Market cap | 136.152M |
| Beta (5Y monthly) | 1.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript May 7, 2024 Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
- GuruFocus.com
Harvard Bioscience Inc (HBIO) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Despite a revenue dip, HBIO maintains robust margins and advances strategic initiatives to bolster future growth.
- GuruFocus.com
Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
First Quarter Reveals Revenue Decline and Net Loss, Despite Strong Gross Margin
© 2024 Yahoo. All rights reserved.